AD Scientific Index
 Open Nav
Login Login Pricing & Plans Pricing & Plans
Michael Baker

Michael Baker

ParisTech Institut des Sciences et Technologies de Paris - Paris / France
Others
AD Scientific Index ID: 920708
ParisTech Paris Institute of Science and Technology
person_outline Michael Baker's MOST POPULAR ARTICLES
1-) Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK The Lancet 397 (10269), 99-111, 2021
2-) Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial The Lancet 396 (10249), 467-478, 2020
3-) The impact of physically attractive models on advertising evaluations Journal of Marketing research 14 (4), 538-555, 1977
4-) Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial The Lancet 396 (10267), 1979-1993, 2020
5-) FCC-ee: The lepton collider: Future circular collider conceptual design report volume 2 The European Physical Journal Special Topics 228 (2), 261-623, 2019